1 – 10 of 70
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Dichotomous Effects of Glypican-4 on Cancer Progression and Its Crosstalk with Oncogenes
(
- Contribution to journal › Article
-
Mark
Interplay between glypican-1, amyloid-β and tau phosphorylation in human neural stem cells
(
- Contribution to journal › Article
- 2023
-
Mark
Interplay between APP and glypican-1 processing and α-synuclein aggregation in undifferentiated and differentiated human neural progenitor cells
(
- Contribution to journal › Article
-
Mark
Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior
(
- Contribution to journal › Article
- 2022
-
Mark
The structure of EXTL3 helps to explain the different roles of bi-domain exostosins in heparan sulfate synthesis
(
- Contribution to journal › Article
-
Mark
Complex modulation of cytokine-induced α-synuclein aggregation by glypican-1-derived heparan sulfate in neural cells
(
- Contribution to journal › Article
-
Mark
Isolation and Characterization of Heparan Sulfate Containing Amyloid Precursor Protein Degradation Products
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Assays for Evaluation of Substrates for and Inhibitors of β-1,4-Galactosyltransferase 7
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Production and HPLC-Based Disaccharide Analysis of Xyloside-Primed Glycosaminoglycans
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2021
-
Mark
Reversal of apolipoprotein E4-dependent or chemical-induced accumulation of APP degradation products by vitamin C-induced release of heparan sulfate from glypican-1
(
- Contribution to journal › Article